Detail Information of Microbiota Influence
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0349 Transporter Info | ||||
Gene Name | SLC39A8 | ||||
Transporter Name | Zinc transporter ZIP8 | ||||
Gene ID | |||||
UniProt ID | |||||
Microbiota Influence of This DT (MBI) | |||||
---|---|---|---|---|---|
Bacteria: Actinomycetota |
|||||
Genus: Corynebacterium |
|||||
Corynebacterium diphtheriae |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [1] , [2] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Corynebactin Secreted by Corynebacterium diphtheriae C7 (beta) has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Mycobacterium |
|||||
Mycobacterium avium |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Carboxymycobactin Secreted by Mycobacterium avium CRl/69 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Mycobacterium tuberculosis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [6] , [7] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein IrtAB of Mycobacterium tuberculosis H37Rv has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Mycolicibacterium |
|||||
Mycolicibacterium vaccae |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [3] , [4] , [6] , [8] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Exochelin 772SM Secreted by Mycolicibacterium vaccae R877R has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacteria: Bacillota |
|||||
Genus: Bacillus |
|||||
Bacillus anthracis |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [3] , [4] , [9] , [10] , [11] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Corynebactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [3] , [4] , [9] , [10] , [11] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [12] , [13] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacillus cereus |
Microbe Info |
Click to Show/Hide the Full List 2 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [3] , [4] , [9] , [10] , [11] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Corynebactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [3] , [4] , [9] , [10] , [11] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Petrobactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacillus subtilis |
Microbe Info |
Click to Show/Hide the Full List 2 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [15] , [16] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein ycdH of Bacillus subtilis ZB307A has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [15] , [16] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein yciC of Bacillus subtilis ZB307A has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacillus thuringiensis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [3] , [4] , [9] , [10] , [11] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Corynebactin Secreted by Bacillus thuringiensis ATCC 33679 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Lactococcus |
|||||
Lactococcus lactis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [18] , [19] | |||
Regulating Factor |
|||||
Detailed Description |
The protein ZitSQP of Lactococcus lactis subsp. lactis Il1403 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Listeria |
|||||
Listeria monocytogenes |
Microbe Info |
Click to Show/Hide the Full List 2 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [20] | |||
Regulating Factor |
|||||
Studied Tissue |
Uterus | ||||
In Vivo Model |
MF1 mice | ||||
In Vitro Model |
Human papillomavirus-related endocervical adenocarcinoma cells (HeLa M) | ||||
Detailed Description |
The protein zinA of Listeria monocytogenes EGD-e has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [20] | |||
Regulating Factor |
|||||
Studied Tissue |
Uterus | ||||
In Vivo Model |
MF1 mice | ||||
In Vitro Model |
Human papillomavirus-related endocervical adenocarcinoma cells (HeLa M) | ||||
Detailed Description |
The protein ZurAM of Listeria monocytogenes EGD-e has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Staphylococcus |
|||||
Staphylococcus aureus |
Microbe Info |
Click to Show/Hide the Full List 9 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [21] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound aureochelin secreted by Staphylococcus aureus has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [9] , [22] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Staphyloferrin A Secreted by Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [1] , [23] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Staphylopine Secreted by Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [24] , [25] , [26] | |||
Regulating Factor |
|||||
Detailed Description |
The protein czra of Staphylococcus aureus has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 5 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [27] , [28] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein FhuCBG of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 6 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [27] , [28] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhuD1 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 7 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [27] , [28] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhud2 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 8 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [1] , [29] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhud2 of Staphylococcus aureus RN2564 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 9 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [30] , [31] , [32] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein MntABC of Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Streptococcus |
|||||
Streptococcus agalactiae |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [33] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein FhuCDB of Streptococcus agalactiae A909 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Streptococcus equi |
Microbe Info |
Click to Show/Hide the Full List 2 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in upper and lower airway disease condition | [15] , [34] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Upper and lower airway disease [ICD11: CA22] | ||||
Studied Tissue |
Lung | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein mtsB of Streptococcus equi subsp. equi NCTC 9682 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [15] , [34] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein mtsB of Streptococcus equi subsp. zooepidemicus NCTC 7023T has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Streptococcus gordonii |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [30] , [31] , [35] | |||
Regulating Factor |
|||||
Detailed Description |
The protein AdcRCBA of Streptococcus gordonii str. Challis has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Streptococcus pneumoniae |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [36] | |||
Regulating Factor |
|||||
Detailed Description |
The protein AdcCBA of Streptococcus pneumoniae D39 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Streptococcus suis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in sepsis condition | [30] , [37] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Sepsis [ICD11: 1G40-1G41] | ||||
Studied Tissue |
Liver | ||||
In Vivo Model |
CD-1 mice | ||||
Detailed Description |
The protein troA of Streptococcus suis serotype 9 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacteria: Campylobacterota |
|||||
Genus: Campylobacter |
|||||
Campylobacter jejuni |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in gastroenteritis condition | [14] , [38] , [39] , [17] | |||
Regulating Factor |
|||||
Studied Phenotype |
Gastroenteritis [ICD11: 1A40] | ||||
Studied Tissue |
Jejunum | ||||
In Vivo Model |
Chicken | ||||
Detailed Description |
The protein znuA of Campylobacter jejuni subsp. jejuni 81-176 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [40] , [41] , [42] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [40] , [43] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein p19 of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacteria: Cyanobacteriota |
|||||
Genus: Synechocystis |
|||||
Synechocystis sp. PCC 6803 |
Microbe Info |
Click to Show/Hide the Full List 4 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [44] , [45] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein futa1 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [44] , [45] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein futa2 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [44] , [45] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein futb of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [44] , [46] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein sll1878 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacteria: Pseudomonadota |
|||||
Genus: Achromobacter |
|||||
Achromobacter xylosoxidans |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Alcaligin Secreted by Achromobacter xylosoxidans subsp. xylosoxydans KN 3-1 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Acinetobacter |
|||||
Acinetobacter baumannii |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [47] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein ZnuABC of Acinetobacter baumannii ATCC 17978 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Bordetella |
|||||
Bordetella bronchiseptica |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [48] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Alcaligin Secreted by Bordetella bronchiseptica B013N has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bordetella pertussis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [48] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Alcaligin Secreted by Bordetella pertussis UT25 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Bradyrhizobium |
|||||
Bradyrhizobium diazoefficiens |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [30] , [49] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein mnoP of Bradyrhizobium diazoefficiens USDA 110 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Brucella |
|||||
Brucella abortus |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [50] , [17] | |||
Regulating Factor |
|||||
Studied Tissue |
Cervix | ||||
In Vivo Model |
BALB/c athymic Nu/Nu mice | ||||
In Vitro Model |
Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa) | ||||
Detailed Description |
The protein znua of Brucella abortus 544 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Burkholderia |
|||||
Burkholderia cepacia |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [51] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Cepabactin Secreted by Burkholderia cepacia ATCC 25416 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [52] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Ornibactin Secreted by Burkholderia cepacia TVV69 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [53] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Salicylic acid Secreted by Burkholderia cepacia Pc275c has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Escherichia |
|||||
Escherichia coli |
Microbe Info |
Click to Show/Hide the Full List 17 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [54] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Aerobactin Secreted by Escherichia coli LG1315 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [55] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Enterobactin Secreted by Escherichia coli BW25113 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [54] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Enterobactin Secreted by Escherichia coli str. K-12 substr. W3110 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [56] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound enterobactin secreted by Escherichia coli 9.0111 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [57] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Enterobactin Secreted by Escherichia coli AB33II has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 6 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [58] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein efeU of Escherichia coli O157:H7 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 7 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [59] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein efeU of Escherichia coli Nissle 1917 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 8 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [60] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fecA of Escherichia coli UT5600 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 9 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [9] , [61] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoA of Escherichia coli str. K-12 substr. MC4100 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 10 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [61] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoB of Escherichia coli str. K-12 substr. MC4100 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 11 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [62] , [63] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhuA of Escherichia coli K-12 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 12 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [62] , [64] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhuB of Escherichia coli DH5[alpha] has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 13 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [62] , [65] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhuC of Escherichia coli AB2847 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 14 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [62] , [66] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fhuD of Escherichia coli BL21(DE3) has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 15 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [67] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein IroA of Escherichia coli CFT073 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 16 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [68] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein ZnuABC of Escherichia coli SB2847 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 17 |
Up regulating of SLC39A8 expression in the health condition | [17] , [69] | |||
Regulating Factor |
|||||
Regulation Mechanism |
via influence on Nuclear factor NF-kappa-B p105 subunit (NFKB1) | Transcription Factor Info | |||
Studied Tissue |
Liver | ||||
In Vivo Model |
C57BL/6 mice | ||||
Detailed Description |
The compound Lipopolysaccharide Generated by Escherichia coli O55 has been reported to increase the expression of the drug transporter SLC39A8. | ||||
Genus: Haemophilus |
|||||
Haemophilus influenzae |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [70] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein FhuCDB of Haemophilus influenzae R2866 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
[Haemophilus] ducreyi |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [15] , [17] , [71] | |||
Regulating Factor |
|||||
Detailed Description |
The protein znuA of [Haemophilus] ducreyi 35000HP has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Klebsiella |
|||||
Klebsiella pneumoniae |
Microbe Info |
Click to Show/Hide the Full List 6 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in pneumonia condition | [1] , [72] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Pneumonia [ICD11: CA40] | ||||
Studied Tissue |
Lung | ||||
In Vivo Model |
C57BL/6 mice | ||||
Detailed Description |
The compound Yersiniabactin Secreted by Klebsiella pneumoniae ATCC 43816 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in lung adenocarcinoma condition | [1] , [73] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Lung cancer [ICD11: 2C25] | ||||
Studied Tissue |
Lung | ||||
In Vitro Model |
Human lung adenocarcinoma cells (A549) | ||||
Detailed Description |
The compound Salmochelin SX Secreted by Klebsiella pneumoniae KP20 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [74] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Lung | ||||
In Vivo Model |
C57BL/6 mice | ||||
Detailed Description |
The compound Salmochelin SX Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [74] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Lung | ||||
In Vivo Model |
C57BL/6 mice | ||||
Detailed Description |
The compound Yersiniabactin Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [75] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Enterobactin Secreted by Klebsiella pneumoniae 298/53 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 6 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [76] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoc of Klebsiella pneumoniae has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Morganella |
|||||
Morganella morganii |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-Oxoadipic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-Methyl-2-oxobutanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-Methyl-2-oxopentanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Indole-3-pyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Phenylpyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Neisseria |
|||||
Neisseria meningitidis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in bacterial meningitis condition | [14] , [17] , [78] | |||
Regulating Factor |
|||||
Studied Phenotype |
Bacterial meningitis [ICD11: 1D01.0] | ||||
Studied Tissue |
Brain | ||||
In Vivo Model |
C57BL/6 mice | ||||
Detailed Description |
The protein ZnuD of Neisseria meningitidis B16B6 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Pasteurella |
|||||
Pasteurella multocida |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [79] | |||
Regulating Factor |
|||||
Studied Tissue |
Intestine | ||||
In Vivo Model |
Swiss mice | ||||
Detailed Description |
The protein ZnuABC of Pasteurella multocida PM25 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Proteus |
|||||
Proteus mirabilis |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-Oxoadipic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Indole-3-pyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Phenylpyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Proteus penneri |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-oxoadipic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-methyl-2-oxobutanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-methyl-2-oxopentanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound indole-3-pyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound phenylpyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Proteus vulgaris |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-Oxoadipic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Indole-3-pyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Phenylpyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Providencia |
|||||
Providencia alcalifaciens |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-oxoadipic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-methyl-2-oxobutanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-methyl-2-oxopentanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound indole-3-pyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound phenylpyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Providencia rustigianii |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-oxoadipic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-methyl-2-oxobutanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-methyl-2-oxopentanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound indole-3-pyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound phenylpyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Providencia stuartii |
Microbe Info |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 2-oxoadipic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 3-methyl-2-oxobutanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound 4-methyl-2-oxopentanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound indole-3-pyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [77] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound phenylpyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Pseudomonas |
|||||
Pseudomonas aeruginosa |
Microbe Info |
Click to Show/Hide the Full List 4 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in cystic fibrosis condition | [80] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | ||||
Studied Tissue |
Lung | ||||
In Vivo Model |
CD-1 mice | ||||
Detailed Description |
The compound Pyochelin Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in cystic fibrosis condition | [80] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Cystic fibrosis [ICD11: CA25] | ||||
Studied Tissue |
Lung | ||||
In Vivo Model |
CD-1 mice | ||||
Detailed Description |
The compound Pyoverdine F-Iib Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [81] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Pyochelin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [82] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Pyoverdin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Salmonella |
|||||
Salmonella enterica |
Microbe Info |
Click to Show/Hide the Full List 15 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [83] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Intestine | ||||
In Vivo Model |
C3H/HeOuJ mice | ||||
Detailed Description |
The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [83] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Intestine | ||||
In Vivo Model |
C3H/HeOuJ mice | ||||
Detailed Description |
The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [84] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [85] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Ferrioxamine B Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [85] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Ferrioxamine E Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 6 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [85] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Ferrioxamine G1 Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 7 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [12] , [86] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 8 |
Sequestration of human SLC39A8 substrates/drugs in colon cancer condition | [14] , [17] , [87] | |||
Regulating Factor |
|||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | ||||
Studied Tissue |
Colon | ||||
In Vitro Model |
Human colon adenocarcinoma cells (Caco-2) | ||||
Detailed Description |
The protein znuA of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 9 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [88] | |||
Regulating Factor |
|||||
Studied Tissue |
Intestine | ||||
In Vivo Model |
C57BL/6 mice | ||||
Detailed Description |
The protein ZnuABC of Salmonella enterica subsp. enterica serovar Typhimurium IR715 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 10 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [89] | |||
Regulating Factor |
|||||
Studied Tissue |
Blood | ||||
In Vivo Model |
BALB/c mice | ||||
Detailed Description |
The protein ZnuABC of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 11 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [90] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoA of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 12 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [91] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 13 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [44] , [90] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 14 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [90] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoC of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 15 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [83] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium JF2043 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Serratia |
|||||
Serratia marcescens |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [44] , [45] , [92] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein sfua of Serratia marcescens has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [45] , [92] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein sfub of Serratia marcescens has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [44] , [45] , [92] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein sfuc of Serratia marcescens has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Shigella |
|||||
Shigella flexneri |
Microbe Info |
Click to Show/Hide the Full List 4 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [9] , [93] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fec of Shigella flexneri 2a has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [94] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feoB of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [94] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein sitA of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 4 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [30] , [31] , [94] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein SitABCD of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Shigella sonnei |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [75] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Enterobactin Secreted by Shigella sonnei 43-GG9 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Genus: Vibrio |
|||||
Vibrio anguillarum |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [95] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound anguibactin secreted by Vibrio anguillarum 775 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [5] , [95] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fata of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [5] , [95] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fatb of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Vibrio cholerae |
Microbe Info |
Click to Show/Hide the Full List 6 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [9] , [96] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Vibriobactin Secreted by Vibrio cholerae Lou15 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [97] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Vibriobactin Secreted by Vibrio cholerae MBG14 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in cholera condition | [14] , [17] , [98] | |||
Regulating Factor |
|||||
Studied Phenotype |
Cholera [ICD11: 1A00] | ||||
Studied Tissue |
Small intestine | ||||
In Vivo Model |
CD-1 mice | ||||
Detailed Description |
The protein ZnuABC of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 4 |
Co-transport of human SLC39A8 substrates/drugs in cholera condition | [14] , [17] , [98] | |||
Regulating Factor |
|||||
Studied Phenotype |
Cholera [ICD11: 1A00] | ||||
Studied Tissue |
Small intestine | ||||
In Vivo Model |
CD-1 mice | ||||
Detailed Description |
The protein ZrgABCDE of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 5 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [99] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein Fbp of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 6 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [99] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein feo of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Yersinia |
|||||
Yersinia enterocolitica |
Microbe Info |
Click to Show/Hide the Full List 2 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [100] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Yersiniabactin Secreted by Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [100] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein fyuA of Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Yersinia pestis |
Microbe Info |
Click to Show/Hide the Full List 8 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [5] , [101] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound Yersiniabactin Secreted by Yersinia pestis Yreka F1+VW+P1+P+ has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in septicemic plague condition | [14] , [17] , [102] | |||
Regulating Factor |
|||||
Studied Phenotype |
Septicemic plague [ICD11: 1B93] | ||||
Studied Tissue |
Blood | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein ZnuABC of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in pneumonic plague condition | [103] , [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Pneumonic plague [ICD11: 1B93.2] | ||||
Studied Tissue |
Lung | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein feo of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 4 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [9] , [104] , [3] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Lung | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein irp2 of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 5 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [9] , [104] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Lung | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein psn of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 6 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [9] , [105] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Blood | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein YfeAB of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 7 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [103] , [4] | |||
Regulating Factor |
|||||
Studied Tissue |
Lung | ||||
In Vivo Model |
Swiss Webster mice | ||||
Detailed Description |
The protein YfeABCD of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 8 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [30] , [31] , [105] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein YfeABCD of Yersinia pestis KIM5-2031.11+ has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Yersinia pseudotuberculosis |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [106] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein tssS of Yersinia pseudotuberculosis YPIII has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Bacteria: Spirochaetota |
|||||
Genus: Treponema |
|||||
Treponema pallidum |
Microbe Info |
Click to Show/Hide the Full List 2 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [107] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Microbe Influence 2 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [107] | |||
Regulating Factor |
|||||
Detailed Description |
The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
Fungi: Ascomycota |
|||||
Genus: Aspergillus |
|||||
Aspergillus fumigatus |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [108] , [109] , [110] | |||
Regulating Factor |
|||||
Detailed Description |
The protein zrfA of Aspergillus fumigatus CETC has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [108] , [109] , [110] | |||
Regulating Factor |
|||||
Detailed Description |
The protein zrfB of Aspergillus fumigatus CETC has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [17] , [108] , [109] , [111] | |||
Regulating Factor |
|||||
Detailed Description |
The protein zrfC of Aspergillus fumigatus CEA17 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Genus: Candida |
|||||
Candida albicans |
Microbe Info |
Click to Show/Hide the Full List 4 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [112] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The protein caftr1 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 2 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [113] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein zrt1 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 3 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [108] , [114] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein ZRT1 of Candida albicans M134 has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Microbe Influence 4 |
Co-transport of human SLC39A8 substrates/drugs in the health condition | [14] , [113] , [17] | |||
Regulating Factor |
|||||
Detailed Description |
The protein zrt2 of Candida albicans has been reported to transport similar substrates/drugs of SLC39A8, which affects the distribution of its substrate/drug in vivo. | ||||
Fungi: Mucoromycota |
|||||
Genus: Rhizopus |
|||||
Rhizopus microsporus |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Sequestration of human SLC39A8 substrates/drugs in the health condition | [1] , [115] , [3] , [4] | |||
Regulating Factor |
|||||
Detailed Description |
The compound rhizoferrin secreted by Rhizopus microsporus has been reported to sequester the substrate/drug of SLC39A8, which may affects its substrate/drug distribution in the body. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.